The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis
Introduction: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are important regulators of metabolism and mediate the incretin effect. This glucose-dependent potentiation of insulin secretion is severely impaired in patients with type-2 diabetes mellitus. While...
Saved in:
| Main Authors: | Bashaier Al-Zaid, Suleiman Al-Sabah |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1528295/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight
by: Claire H. Feetham, et al.
Published: (2025-09-01) -
Emerging concepts in obesity management: focus on glucagon receptor agonist combinations
by: Sarah L Anderson
Published: (2025-07-01) -
Adipocytokine levels in patients with atherosclerosis and high triglyceride – glucose index
by: E. V. Garbuzova, et al.
Published: (2024-10-01) -
The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.
by: Suleiman Al-Sabah, et al.
Published: (2014-01-01) -
Tirzepatide: A dual action approach to weight reduction and glycemic control in type 2 diabetes mellitus
by: Princy Domnic Dsouza, et al.
Published: (2025-01-01)